Majorini MT - Search Results

1

Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy.

Bellone M, Brevi A, Bruzzì S, Consonni M, De Santis F, Di Lullo G, Majorini MT, Pastò A, Amadori A, Bregni M, Di Nicola M, Calabrò L, Ferrucci PF, Proietti E, Colombo MP, Russo V. Bellone M, et al. Among authors: majorini mt. Cancer Immunol Immunother. 2020 Jun;69(6):1141-1151. doi: 10.1007/s00262-020-02502-1. Epub 2020 Feb 6. Cancer Immunol Immunother. 2020. PMID: 32025818 Free PMC article. No abstract available.

2

Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors.

Majorini MT, Colombo MP, Lecis D. Majorini MT, et al. Cancer Res. 2022 Apr 15;82(8):1439-1447. doi: 10.1158/0008-5472.CAN-21-3424. Cancer Res. 2022. PMID: 35045983 Free PMC article. Review.

3

Infiltrating Mast Cell-Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype.

Majorini MT, Cancila V, Rigoni A, Botti L, Dugo M, Triulzi T, De Cecco L, Fontanella E, Jachetti E, Tagliabue E, Chiodoni C, Tripodo C, Colombo MP, Lecis D. Majorini MT, et al. Cancer Res. 2020 Jun 1;80(11):2311-2324. doi: 10.1158/0008-5472.CAN-19-3596. Epub 2020 Mar 16. Cancer Res. 2020. PMID: 32179512

4

cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells.

Majorini MT, Manenti G, Mano M, De Cecco L, Conti A, Pinciroli P, Fontanella E, Tagliabue E, Chiodoni C, Colombo MP, Delia D, Lecis D. Majorini MT, et al. Cell Death Differ. 2018 Dec;25(12):2147-2164. doi: 10.1038/s41418-018-0100-0. Epub 2018 Apr 19. Cell Death Differ. 2018. PMID: 29674627 Free PMC article.

5

Lemur tyrosine kinase 2 (LMTK2) is a determinant of cell sensitivity to apoptosis by regulating the levels of the BCL2 family members.

Conti A, Majorini MT, Fontanella E, Bardelli A, Giacca M, Delia D, Mano M, Lecis D. Conti A, et al. Among authors: majorini mt. Cancer Lett. 2017 Mar 28;389:59-69. doi: 10.1016/j.canlet.2016.12.025. Epub 2016 Dec 29. Cancer Lett. 2017. PMID: 28040547

6

Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathway.

Conti A, Majorini MT, Elliott R, Ashworth A, Lord CJ, Cancelliere C, Bardelli A, Seneci P, Walczak H, Delia D, Lecis D. Conti A, et al. Among authors: majorini mt. Oncotarget. 2015 May 10;6(13):10994-1008. doi: 10.18632/oncotarget.3552. Oncotarget. 2015. PMID: 26028667 Free PMC article.

7

MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner.

Andriani F, Majorini MT, Mano M, Landoni E, Miceli R, Facchinetti F, Mensah M, Fontanella E, Dugo M, Giacca M, Pastorino U, Sozzi G, Delia D, Roz L, Lecis D. Andriani F, et al. Among authors: majorini mt. J Hematol Oncol. 2018 Mar 20;11(1):45. doi: 10.1186/s13045-018-0594-4. J Hematol Oncol. 2018. PMID: 29558956 Free PMC article.

8

Structure-based identification of a new IAP-targeting compound that induces cancer cell death inducing NF-κB pathway.

Cossu F, Camelliti S, Lecis D, Sorrentino L, Majorini MT, Milani M, Mastrangelo E. Cossu F, et al. Among authors: majorini mt. Comput Struct Biotechnol J. 2021 Nov 26;19:6366-6374. doi: 10.1016/j.csbj.2021.11.034. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34938412 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page